Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Tang

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Endocrine-Related Cancer|February 28, 2021
Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumorsNitya Raj, Youyun Zheng, Haley Hauser, et al.
International Journal of Cancer|February 11, 2014
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancerChristiane Daniela Fichter, Sylvia Timme, Julia Alexandra Braun, et al.
Annals of Surgery|August 3, 2017
Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ AdenocarcinomaJonathan M Hernandez, Volkan Beylergil, Debra A Goldman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 8, 2026
Mepilex Lite dressing in the management of radiation dermatitis-a systematic review and meta-analysis of randomized controlled trialsHenry C Y Wong, Britney Zhang, Shely Kagan, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Loss of <i>Kmt2c</i> / <i>d</i> promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapyNaitao Wang, Dan Li, Tao Zhang, et al.
Histopathology|June 20, 2026
High interobserver variability exists in grading appendiceal goblet cell adenocarcinoma using World Health Organization 5th edition criteriaLidiane Vieira Marins, Raphiel Murden, Joseph Misdraji, et al.
Plos One|June 4, 2019
Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibitionAmy Allen, Alice Can Ran Qin, Nitya Raj, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
The Journal of Clinical Investigation|May 12, 2026
Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD1 inhibitionNaitao Wang, Dan Li, Tao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2020
Treatment of Locally Advanced Esophageal Carcinoma: ASCO GuidelineManish A Shah, Erin B Kennedy, Daniel V Catenacci, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Endocrine-Related Cancer|February 28, 2021
Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumorsNitya Raj, Youyun Zheng, Haley Hauser, et al.
International Journal of Cancer|February 11, 2014
EGFR, HER2 and HER3 dimerization patterns guide targeted inhibition in two histotypes of esophageal cancerChristiane Daniela Fichter, Sylvia Timme, Julia Alexandra Braun, et al.
Annals of Surgery|August 3, 2017
Post-Treatment/Pre-operative PET Response Is Not an Independent Predictor of Outcomes for Patients With Gastric and GEJ AdenocarcinomaJonathan M Hernandez, Volkan Beylergil, Debra A Goldman, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 8, 2026
Mepilex Lite dressing in the management of radiation dermatitis-a systematic review and meta-analysis of randomized controlled trialsHenry C Y Wong, Britney Zhang, Shely Kagan, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Loss of <i>Kmt2c</i> / <i>d</i> promotes gastric cancer initiation and confers vulnerability to mTORC1 inhibition and anti-PD1 immunotherapyNaitao Wang, Dan Li, Tao Zhang, et al.
Histopathology|June 20, 2026
High interobserver variability exists in grading appendiceal goblet cell adenocarcinoma using World Health Organization 5th edition criteriaLidiane Vieira Marins, Raphiel Murden, Joseph Misdraji, et al.
Plos One|June 4, 2019
Rare BRAF mutations in pancreatic neuroendocrine tumors may predict response to RAF and MEK inhibitionAmy Allen, Alice Can Ran Qin, Nitya Raj, et al.
Frontiers in Oncology|January 5, 2026
Sensitivity of metastatic mucinous tailgut cyst adenocarcinoma to gemcitabine and radiation: a case reportMaliha Nusrat, Kenneth H Yu, Laura Tang, et al.
The Journal of Clinical Investigation|May 12, 2026
Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD1 inhibitionNaitao Wang, Dan Li, Tao Zhang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2020
Treatment of Locally Advanced Esophageal Carcinoma: ASCO GuidelineManish A Shah, Erin B Kennedy, Daniel V Catenacci, et al.
Pageof 10